Vaccines for hepatitis A and B: The latest recommendations on safe and extended protection

Postgraduate Medicine

Volumn 102, Issue 6, 1997, Pages 74-80

  Dolan, Stephen A ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN;

CLINICAL TRIAL; CONFERENCE PAPER; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; VACCINATION;

EID: 0031437413     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.12.377     Document Type: Conference Paper

References (19)

1. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997;336(3):196-204
2. Kane MA. Perspectives on the control of hepatitis A by vaccination. Vaccine 1992;10 Suppl 1:93-6S
3. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis 1995;171(Suppl 1):2-8S
4. Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991:14-20
5. Koff RS. Seroepidemiology of hepatitis A in the United States. J Infect Dis 1995;171(Suppl 1):19-23S
6. Lemon SM, Jansen RW, Brown EA. Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine 1992;10 Suppl 1:40-4S
7. Van Damme P, Thoelen S, Cramm M, et al. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994;44(4):446-51
8. Wiens BL, Bohidar NR, Pigeon JG, et al. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA. J Med Virol 1996;49(3):235-41
9. Green MS, Cohen D, Lerman Y, et al. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis 1993;168(3):740-3
10. Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271(17):1328-34
11. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992;327(7):453-7
12. Gardner P, Eickhoff T, Poland GA, et al. Adult immunizations. Ann Intern Med 1996; 124(1 Pt 1):35-40
13. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(RR-15):1-30
14. Stapleton JT. Host immune response to hepatitis A virus. J Infect Dis 1995;171(Suppl 1):9-14S
15. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995;20(4):992-1000
16. Katkov WN. Hepatitis vaccines. Med Clin North Am 1996; 80(5):1189-200
17. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1-25
18. Chang MH, Chen CJ, Lai MS, et al, for the Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336(26):1855-9
19. Guide for adult immunization. 3d ed. Philadelphia: American College of Physicians, 1994:75-83